RestructuringApr 9, 2026, 04:37 PM
Wellgistics Health Terminates Settlement Agreement with Silverback Capital, Halting Future Dilution After Issuing 6.87M Shares
AI Summary
Wellgistics Health, Inc. announced the termination of its Settlement Agreement and Stipulation with Silverback Capital Inc., effective April 3, 2026. The agreement, originally dated January 28, 2026, had led to the issuance of 6,866,000 shares of the Company's common stock prior to its termination. This strategic move eliminates potential future dilution associated with the settlement structure, allowing Wellgistics to pursue alternative strategic and financing initiatives. As a result, no additional shares will be issued under the agreement, and Silverback Capital Inc. has been requested to return all rights to any unpaid claims to applicable creditors.
Key Highlights
- Wellgistics Health, Inc. delivered written notice on April 3, 2026, to Silverback Capital Inc. to terminate their Settlement Agreement and Stipulation, originally dated January 28, 2026.
- Prior to termination, the Company had issued an aggregate of 6,866,000 shares of its common stock pursuant to the Settlement Agreement.
- The termination ensures that no additional shares will be issued by Wellgistics Health under the Settlement Agreement, thereby eliminating potential future dilution.
- Silverback Capital Inc. has been requested to return all rights, title, and interest in and to any unpaid claims to the applicable creditors.
- The Company elected to terminate the settlement structure to pursue alternative strategic and financing initiatives.
- Both Wellgistics Health and Silverback Capital Inc. have no further obligations under the terminated Settlement Agreement.